Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Advanced Micro Devices | AMD | Sep 19, 2024 | 156.74 | +5.70 |
AdvanSix | ASIX | Sep 19, 2024 | 29.13 | +2.53 |
Advantage Solutions A | ADV | Sep 19, 2024 | 4.00 | +2.83 |
Advent | AVK | Sep 19, 2024 | 12.17 | +0.91 |
Advent Technologies A | ADN | Sep 19, 2024 | 3.38 | +22.46 |
Adverum Biotechnologies | ADVM | Sep 19, 2024 | 7.50 | +7.30 |
AdvisorShares Pure US Cannabis ETF | MSOS | Sep 19, 2024 | 6.86 | +0.73 |
Advisorshares Star Global Buy-Write ETF | VEGA | Sep 19, 2024 | 43.72 | +0.74 |
AECOM | ACM | Sep 19, 2024 | 101.24 | +3.05 |
Aegon N.V ADR | AEG | Sep 19, 2024 | 6.28 | +3.63 |
Aehr Test Systems | AEHR | Sep 19, 2024 | 12.98 | +7.27 |
Aemetis | AMTX | Sep 19, 2024 | 2.54 | +3.67 |
Aeon Biopharma | AEON | Sep 19, 2024 | 0.67 | -0.15 |
AerCap Holdings | AER | Sep 19, 2024 | 98.28 | +4.40 |
Aeries Technology | AERT | Sep 19, 2024 | 2.35 | +6.33 |
Aerospace & Defense Powershares | PPA | Sep 19, 2024 | 113.20 | +1.23 |
Aerovate Therapeutics | AVTE | Sep 19, 2024 | 1.98 | +3.66 |
AeroVironment | AVAV | Sep 19, 2024 | 179.69 | +3.01 |
AerSale | ASLE | Sep 19, 2024 | 5.47 | +7.89 |
AES | AES | Sep 19, 2024 | 18.90 | -1.87 |
Aetherium Acquisition A | GMFI | Sep 19, 2024 | 11.04 | 0.00 |
Aetherium Acquisition Unit | GMFIU | Sep 19, 2024 | 11.10 | 0.00 |
Aethlon Medical | AEMD | Sep 19, 2024 | 0.39 | +8.82 |
Aeva Technologies | AEVA | Sep 19, 2024 | 3.15 | +9.38 |
AEye A | LIDR | Sep 19, 2024 | 1.19 | +3.48 |
AFC Gamma | AFCG | Sep 19, 2024 | 10.75 | +1.03 |
Affiliated Managers Group | AMG | Sep 19, 2024 | 179.74 | +2.26 |
Affimed N.V. | AFMD | Sep 19, 2024 | 3.96 | -1.49 |
Affinity Bancshares | AFBI | Sep 19, 2024 | 21.53 | +0.37 |
Affirm A | AFRM | Sep 19, 2024 | 44.98 | +1.58 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.